Subtle signs of neurodegeneration can be detected in blood, CSF, and neuroimaging, up to 20 years before the motor symptoms ...

Huntington's disease is a hereditary disorder caused by a genetic mutation in the HTT gene, leading to progressive brain cell ...

Beta blockers were associated with later appearance of motor symptoms and slower symptom worsening, but an outside expert ...

A recent study published in Cell reveals that the repeated DNA sequence that leads to Huntington’s disease (HD) expands ...

The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat ...

Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately twenty years before a clinical motor diagnosis in people with Huntington's ...

Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately twenty years before a clinical motor diagnosis in people with Huntington's ...

About 2,000 people in Australia are affected by Huntington's disease, a fatal and incurable condition that affects the ...

The oversubscribed Series B will boost the clinical development of two RNAi therapies for epilepsy and Huntington’s disease ...

Carol Lynn Balkus, nee Carol Lynn Fry, who passed away January 15, 2025, at her home in Rio Rancho, New Mexico after a long ...

Atalanta Therapeutics, a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases, today announced the completion of a $97 million Series B financing to ...